Article

Urology Times to add peer-reviewed clinical content to editorial mix

Urology Times has announced the expansion of its editorial content in 2008. Beginning in March, the publication’s content mix will be expanded to include practical, peer-reviewed clinical articles in a quarterly supplement known as Urology Times Clinical Edition. This addition will complement the publication’s current offerings: news from major meetings, Q&A interviews with urology’s thought leaders, analysis of legislation affecting urologists, and valuable practice management information.

Urology Times has announced the expansion of its editorial content in 2008. Beginning in March, the publication’s content mix will be expanded to include practical, peer-reviewed clinical articles in a quarterly supplement known as Urology Times Clinical Edition. This addition will complement the publication’s current offerings: news from major meetings, Q&A interviews with urology’s thought leaders, analysis of legislation affecting urologists, and valuable practice management information.

Articles will be similar in format to those that have appeared in Urology Times’ sister publication, Contemporary Urology: accurate, balanced, and comprehensive contributions from experts in the field. At that same time, Contemporary Urology will be discontinued after publication of its January 2008 issue to consolidate efforts behind Urology Times’ new content strategy.

“The goal is a simple one: to ensure that clinical urologists receive the most current, relevant news and information that will enable them to remain at the forefront of their specialty,” said Richard R. Kerr, editor-in-chief of Urology Times.

Please address questions or comments to Kerr at dkerr@advanstar.com.

Related Videos
Woman having telemedicine appointment with doctor | Image Credit: © Jacob Lund - stock.adobe.com
Alexander Pastuszak, MD, PhD: Is hormone therapy safe after prostate cancer radiotherapy?
Refining prostate cancer therapy strategy to address RAPTOR findings
Considering patient-reported outcomes in kidney cancer care, with Nicholas Zaorsky, MD, PhD
Soumyajit Roy, MS, MBBS: The effect of prostate cancer patient history in RAPTOR
 Nicholas Zaorsky, MD, MS: Protecting kidney function after local renal cell carcinoma therapy
Daniel Carson, MD, MS, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.